by Frank Bergman, Slay News:

Pfizer is investing billions of dollars in treatments to prepare for a looming “heart failure pandemic.”

The Covid mRNA vaccine maker is making a big investment in treatment for heart failure as cases of myocarditis and sudden cardiac deaths skyrocket.

The pharmaceutical giant recently acquired several companies.

This includes a major $6.7 billion cash acquisition of Arena Pharmaceuticals.

Arena Pharmaceuticals is a firm specializing in developing treatments, particularly for heart inflammation conditions like myocarditis and pericarditis.